Page last updated: 2024-09-04

methyl 5-aminolevulinate and Atypical Mycobacterial Infection, Disseminated

methyl 5-aminolevulinate has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Algara, O; Almenara-Blasco, M; Cerro-Muñoz, P; Gilaberte, Y; Gracia-Cazaña, T; Navarro-Bielsa, A1

Other Studies

1 other study(ies) available for methyl 5-aminolevulinate and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Multiresistant Mycobacterium abscessus ulcer treated with photodynamic therapy with methyl-aminolevulinate.
    Dermatologic therapy, 2022, Volume: 35, Issue:10

    Topics: Aminolevulinic Acid; Anti-Bacterial Agents; Humans; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Photochemotherapy; Ulcer

2022